JP2023504264A5 - - Google Patents

Info

Publication number
JP2023504264A5
JP2023504264A5 JP2022532731A JP2022532731A JP2023504264A5 JP 2023504264 A5 JP2023504264 A5 JP 2023504264A5 JP 2022532731 A JP2022532731 A JP 2022532731A JP 2022532731 A JP2022532731 A JP 2022532731A JP 2023504264 A5 JP2023504264 A5 JP 2023504264A5
Authority
JP
Japan
Prior art keywords
rna
nucleotides
optionally
stem
ligase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022532731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504264A (ja
JP7826199B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063084 external-priority patent/WO2021113494A1/en
Publication of JP2023504264A publication Critical patent/JP2023504264A/ja
Publication of JP2023504264A5 publication Critical patent/JP2023504264A5/ja
Priority to JP2026028113A priority Critical patent/JP2026113460A/ja
Application granted granted Critical
Publication of JP7826199B2 publication Critical patent/JP7826199B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022532731A 2019-12-03 2020-12-03 合成ガイドrna、組成物、方法、およびそれらの使用 Active JP7826199B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026028113A JP2026113460A (ja) 2019-12-03 2026-02-25 合成ガイドrna、組成物、方法、およびそれらの使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962943158P 2019-12-03 2019-12-03
US62/943,158 2019-12-03
US202063031262P 2020-05-28 2020-05-28
US63/031,262 2020-05-28
PCT/US2020/063084 WO2021113494A1 (en) 2019-12-03 2020-12-03 Synthetic guide rna, compositions, methods, and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026028113A Division JP2026113460A (ja) 2019-12-03 2026-02-25 合成ガイドrna、組成物、方法、およびそれらの使用

Publications (3)

Publication Number Publication Date
JP2023504264A JP2023504264A (ja) 2023-02-02
JP2023504264A5 true JP2023504264A5 (enExample) 2023-12-11
JP7826199B2 JP7826199B2 (ja) 2026-03-09

Family

ID=73854975

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022532731A Active JP7826199B2 (ja) 2019-12-03 2020-12-03 合成ガイドrna、組成物、方法、およびそれらの使用
JP2026028113A Pending JP2026113460A (ja) 2019-12-03 2026-02-25 合成ガイドrna、組成物、方法、およびそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026028113A Pending JP2026113460A (ja) 2019-12-03 2026-02-25 合成ガイドrna、組成物、方法、およびそれらの使用

Country Status (8)

Country Link
US (1) US20230055682A1 (enExample)
EP (1) EP4069838A1 (enExample)
JP (2) JP7826199B2 (enExample)
KR (1) KR20220123398A (enExample)
CN (1) CN121759549A (enExample)
AU (1) AU2020398213A1 (enExample)
CA (1) CA3162908A1 (enExample)
WO (1) WO2021113494A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220259617A1 (en) 2019-06-13 2022-08-18 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
BR112023001272A2 (pt) 2020-07-24 2023-04-04 Massachusetts Gen Hospital Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
US20230220379A1 (en) * 2021-09-24 2023-07-13 Crispr Therapeutics Ag HIGH PURITY gRNA SYNTHESIS PROCESS
US20250223584A2 (en) 2021-12-03 2025-07-10 The Broad Institute, Inc. Compositions and methods for efficient in vivo delivery
AU2023261324A1 (en) * 2022-04-25 2024-11-14 Huidagene Therapeutics (Singapore) Pte. Ltd. Novel crispr-cas12f systems and uses thereof
JP2025519070A (ja) 2022-05-17 2025-06-24 エンヴェロップ セラピューティクス, インコーポレイテッド 効率的in vivo送達のための組成物および方法
WO2024003810A1 (en) * 2022-06-30 2024-01-04 Geneditbio Limited Guide rna with chemical modifications
EP4615424A1 (en) 2022-11-10 2025-09-17 Sail Biomedicines, Inc. Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
KR20260007576A (ko) * 2023-04-28 2026-01-14 빔 테라퓨틱스, 인크. 변형된 가이드 rna
WO2025114441A1 (en) * 2023-11-30 2025-06-05 F. Hoffmann-La Roche Ag Single guide rna synthesis
WO2025215514A1 (en) * 2024-04-08 2025-10-16 Crispr Therapeutics Ag Splint-mediated rna synthesis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4921757A (en) 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
JPH0825869B2 (ja) 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
US4917951A (en) 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
EP2397490B1 (en) 2004-07-16 2013-09-04 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
JP2011512326A (ja) 2007-12-31 2011-04-21 ナノコア セラピューティクス,インコーポレイテッド 心不全の治療用のrna干渉
US9187746B2 (en) * 2009-09-22 2015-11-17 Alnylam Pharmaceuticals, Inc. Dual targeting siRNA agents
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US10073635B2 (en) 2014-12-01 2018-09-11 Micron Technology, Inc. Multiple endianness compatibility
EP4019635A1 (en) * 2015-03-25 2022-06-29 Editas Medicine, Inc. Crispr/cas-related methods, compositions and components
CN105139759B (zh) 2015-09-18 2017-10-10 京东方科技集团股份有限公司 一种拼接屏
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
WO2017180711A1 (en) * 2016-04-13 2017-10-19 Editas Medicine, Inc. Grna fusion molecules, gene editing systems, and methods of use thereof
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
US20210115485A1 (en) * 2018-03-30 2021-04-22 Sumitomo Chemical Company, Limited Method for producing single-strand rna
EP3778886A4 (en) * 2018-03-30 2022-11-02 Toray Industries, Inc. Method for producing hairpin single-stranded rna molecule
CA3159799A1 (en) * 2019-12-02 2021-06-10 Prashant MALI Engineering circular guide rnas

Similar Documents

Publication Publication Date Title
JP7531537B2 (ja) オリゴヌクレオチドの産生のための新規プロセス
CN113874504B (zh) 核酸构建体和其制造方法
JP7438259B2 (ja) オリゴヌクレオチドの産生のための新規プロセス
RU2017130143A (ru) Гибридные днк/рнк-полинукдеотиды crispr и способы
WO2007032837A2 (en) Method for in vitro recombination
JP2022524435A5 (enExample)
JP2015521857A (ja) 5’保護に依存した増幅
CN115335521A (zh) 合成rna分子的方法
CN119193713A (zh) 修饰的双链供体模板
JP6006814B2 (ja) 核酸増幅用プライマーの設計方法、核酸増幅用プライマーの製造方法、核酸増幅用プライマー、プライマーセット、および核酸の増幅方法
US20240352443A1 (en) Method for generating double-stranded nucleic acid
CN115491399A (zh) 一种制备腺苷酸化核酸产物的方法
CN103013953B (zh) 一种剪切dna的dna酶
KR20240005893A (ko) 올리고뉴클레오티드 풀로부터 유전자의 조립
JP2025510151A5 (enExample)
EP2774996B1 (en) A method for production of single-stranded nucleic acids
Boiziau et al. A method to select chemically modified aptamers directly
JP7333171B2 (ja) Rna検出方法、rna検出用核酸及びrna検出用キット
JP5129498B2 (ja) 核酸クローニング法
CN121950969A (zh) 寡核苷酸的制备方法
JP4681129B2 (ja) 核酸末端領域の非対称的修飾法
WO2025172578A1 (en) A nucleic acid assembly method using type iib enzymes
US9297041B1 (en) Inexpensive autonomous assembly of ultra-large (UL) DNA constructs
WO2023203082A2 (en) Method for producing double stranded dna
CN121046381A (zh) 一种基于d型dna结构的抗降解反义核酸及其制备方法和应用